These tumors present in advanced-stage disease more often than cancers of the tonsillar pillar.
Clinical trials are addressing the role of more intensive regimens for patients with advanced-stage disease and poor prognostic factors.
Chemotherapy is usually reserved for patients with advanced-stage disease who have not responded to radiation therapy or steroids.
Some women with advanced-stage disease may choose not to have treatment because the time, costs, and side effects of treatment may be greater than the benefits.
Other therapies as designated for patients with advanced-stage disease.
Since none of these therapies are curative for advanced-stage disease, innovative approaches are under clinical evaluation.
"For advanced-stage disease, lung cancer is 90 to 95 percent fatal when diagnosed."
In the German study, the benefit of radiation therapy was greater in patients with advanced-stage disease at presentation.
Elevated TATI is more likely to be see in patients with advanced-stage disease.
A combination of ifosfamide, cisplatin, and doxorubicin has also been successfully used in the treatment of advanced-stage disease.
